Agilon Health, Inc. Hits New 52-Week High of $98.92

Agilon Health, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 98.92 on June 5, 2026. This achievement marks a remarkable performance over the past year, with the stock soaring by an impressive 1345.52%, significantly outpacing the S&P 500's growth of 24.32% during the same period. With a market capitalization of USD 164 million, Agilon Health operates in a competitive industry characterized by rapid innovation and evolving market dynamics. Despite its recent stock performance, the company remains in a loss-making position, reflected in its negative price-to-earnings ratio and return on equity of -286.57%. The stock's price-to-book ratio stands at 1.30, indicating its valuation relative to its net assets. As Agilon Health continues to navigate the complexities of the pharmaceuticals and biotechnology landscape, its recent price achievement underscores the volatility and potential within this sector.